[Fluconazole in the treatment of esophageal, bronchial and oral candidiasis in patients with ARC and AIDS].
Gritti
F M
FM
Raise
E
E
Di Salvo
S
S
Vannini
V
V
Lanzoni
G
G
Cucci
A M
AM
D000386:AIDS-Related Complex / Q000150:complications*; D000163:Acquired Immunodeficiency Syndrome / Q000150:complications*; D000328:Adult; D000935:Antifungal Agents / Q000627:therapeutic use*; D001991:Bronchitis / Q000188:drug therapy; D002177:Candidiasis / Q000150:complications / Q000188:drug therapy*; D002180:Candidiasis, Oral / Q000188:drug therapy; D004341:Drug Evaluation; D004941:Esophagitis / Q000188:drug therapy; D005260:Female; D015725:Fluconazole; D006801:Humans; D007654:Ketoconazole / Q000627:therapeutic use; D008297:Male; D008875:Middle Aged; D009894:Opportunistic Infections / Q000150:complications / Q000188:drug therapy*; D011897:Random Allocation; D014230:Triazoles / Q000627:therapeutic use*
D000935:Antifungal Agents; D014230:Triazoles; D015725:Fluconazole; D007654:Ketoconazole
Il fluconazolo nel trattamento della candidosi esofagea, bronchiale e orale in pazienti affetti da ARC e AIDS.